A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an E1B-Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Molecular Therapy

Topics

Medicine

Cancer Oncology

Internal Medicine

Surgery

Gastroenterology

Show all topics

DOI

10.1016/j.ymthe.2004.07.021

License

CC-BY-NC-ND

Other Formats

PDF